Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Granules India Ltd

+ Add to Watchlist

GRAN:IN

82.15 INR 0.75 0.92%

As of 07:05:53 ET on 04/30/2015.

Snapshot for Granules India Ltd (GRAN)

Open: 81.85 Day's Range: 80.00 - 83.00 Volume: 1,126,901
Previous Close: 81.40 52wk Range: 33.86 - 104.40 1-Yr Rtn: +130.77%

Stock Chart for GRAN

No chart data available.
  • GRAN:IN 82.15
  • 1D
  • 1M
  • 1Y
81.40
Interactive GRAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GRAN

Current P/E Ratio (ttm) 18.4193
Estimated P/E(03/2016) 13.0937
Relative P/E vs. SENSEX -
Earnings Per Share (INR) (ttm) 4.4600
Est. EPS (INR) (03/2016) 6.2740
Est. PEG Ratio -
Market Cap (M INR) 16,779.26
Shares Outstanding (M) 204.25
30 Day Average Volume 3,277,081
Price/Book (mrq) 3.8916
Price/Sale (ttm) 1.2951
Dividend Indicated Gross Yield 0.61%
Cash Dividend (INR) 0.5000
Dividend Ex-Date
5 Year Dividend Growth 22.87%
Next Earnings Announcement 07/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GRAN

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for GRAN

Granules India Limited is a global pharmaceutical company engaged in the manufacturing and selling of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs).

Chigurupati Krishna PrasadChairman/Managing DirectorV V S MurthyChief Financial Officer
Stefan LohleChief Marketing OfficerB Madhusudan RaoChief Operating Officer
More Company Profile & Key Executives for GRAN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil